ReviewInternational journal of clinical pharmacy2026
Research trends and emerging topics in antifungal therapeutic drug monitoring: a bibliometric analysis with implications for clinical pharmacy practice.
Review in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionTherapeutic drug monitoring (TDM) plays an important role in optimizing antifungal pharmacotherapy because of the substantial pharmacokinetic variability and narrow therapeutic window of many antifungal agents. However, the global research landscape and emerging trends in antifungal TDM have not been systematically evaluated.
aimThis study aimed to analyze global research trends, collaboration networks, and emerging research hotspots in antifungal TDM using bibliometric analyses.
methodRelevant publications published between January 2014 and November 14, 2024, were retrieved from the Web of Science Core Collection. Bibliometric analyses were performed using CiteSpace and VOSviewer to evaluate publication trends, countries, institutions, authors, journals, and keyword co-occurrence.
resultsA total of 569 publications from 34 countries were included in this review. The United States, China, and Germany were the leading contributors, and the annual publication output increased steadily during the study period. The French National Institute of Health and Medical Research was the most productive institution. The most influential journals were Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection. Keyword analysis identified voriconazole TDM, drug-drug interactions, caspofungin, invasive aspergillosis, extracorporeal membrane oxygenation, and immunocompromised pediatric populations as major research hotspots. Machine learning-assisted pharmacokinetic modeling has recently emerged as a research focus.
conclusionAlthough research on antifungal TDM is increasing globally, high-quality clinical evidence remains limited. Future research should prioritize multicenter clinical studies, optimization of TDM implementation in special populations, and integration of model-informed precision dosing approaches to support individualized antifungal therapy and clinical pharmacy practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.